Bids Are Invited For Future And Fractional Acquisition Of Medicines, To Meet The Needs Of The Municipal Emergency Care And Basic Health Units, According To Specifications Described In The Terms Of Reference

Ascorbic Acid, Dosage:100 Mg/Ml, Type Of Use:Injectable; Ampoule 5 Ml0271687, Tranexamic Acid, Dosage:50 Mg/Ml, Pharmaceutical Form:Injectable Solution; Ampoule 5 Ml0327566, Adenosine, Dosage:3 Mg/Ml, Indication:Injectable Solution; Ampoule 2 Ml0278281, Distilled Water, Physical Appearance: Double-Distilled, Sterile, Non-Pyrogenic. Ampoule 5Ml0315056, Physical Aspect: Sterile And Pyrogenic; Ampoule 10Ml0352317, 06/24/2024, Aminophylline, Dosage:24 Mg/Ml, Pharmaceutical Form: Injectable Solution; Ampoule 10 Ml0292402, Amiodarone, Dosage:50Mg/Ml, Indication:Injectable; Ampoule 3 Ml0271710, Atropine Sulfate, Dosage:0.25 Mg/Ml, Use: Injectable Solution; Ampoule 1 Ml0268214, Benzylpenicillin, Presentation: Benzathine, Dosage:1,200,000Ui, Use: Injectable0270612, Dosage:600,000Ui, Use:Injectable0270613, Betamethasone, Composition: Dipropionate, Presentation:Associated With Betamethasone Phosphate, Dosage:5Mg + 2 Mg, Usage: Injectable0270590, Bromopride, Dosage:5 Mg/Ml, Presentation:Injectable; Ampoule 2Ml0269958, Activated Charcoal, Pharmaceutical Form: Powder; Sachet 10 Grams, Cephalotin Sodium, 1 G, Injectable0268228, Ceftriaxone Sodium, Concentration: 1 G, Pharmaceutical Form: Powder For Intravenous Injection Solution0442701, Pharmaceutical Form: Powder For Injectable Solution + Diluent0450890, Concentration: 500 Mg, Pharmaceutical Form: Powder For Injectable Solution + Lidocaine0469930, Ketoprofen, Concentration:100 Mg, Pharmaceutical Form: Lyophilic Powder For Injection0448844, Concentration:50 Mg/Ml, Pharmaceutical Form:Injectable Solution0448845, Cimetidine, Concentration:150 Mg/Ml, Pharmaceutical Form:Injectable Solution ; Ampoule 2Ml0340167, Clonidine Hydrochloride, Concentration:0.1 Mg0272043, Concentration:0.15 Mg/Ml, Pharmaceutical Form:Injectable Solution; Ampoule 1Ml0340206, Clopidogrel, Dosage:75 Mg0272045, Potassium Chloride, Dosage:19.1%, Presentation:Injectable Solution; Ampoule 10 Ml0267162, Sodium Chloride, Active Ingredient:0.9%_ Injectable Solution, Application:Closed System; Ampoule 10 Ml0268236, Application:Closed System; Bottle 100 Ml0268236, Application:Closed System; Bottle 250 Ml0268236, Application:Closed System; Bottle 500 Ml0268236, Application:Closed System; Bottle 1000 Ml0268236, Chlorpromazine, Dosage: 5 Mg/Ml, Presentation: Injectable Solution; Ampoule 5 Ml0268069, Deslanoside, Dosage: 0.2 Mg/Ml, Presentation: Injectable Solution0276283, Dexamethasone, Concentration: 2 Mg/Ml, Pharmaceutical Form: Injectable Solution0300733, Dosage: 4 Mg/Ml, Pharmaceutical Form: Injectable Solution0292427, Oh, Concentration:10 Mg/Ml, Pharmaceutical Form:Injectable Solution0395147, Diclofenac, Presentation: Sodium Salt, Dosage:25Mg/Ml, Use:Injectable Solution0271003, Dimenhydrinate, Presentation:Associated With Pyridoxine + Glucose + Fructose, Dosage:3Mg + 5Mg + 100Mg + 100Mg/Ml, Medication Type: Injectable Solution; Ampoule 10 Ml0272336, Presentation:Associated With Pyridoxine Hydrochloride, Dosage:50Mg + 50Mg/Ml, Medication Type:Injectable Solution0272334, Sodium Dipyrone, Dosage: 500 Mg/Ml, Presentation:Injectable Solution0268252, Dobutamine Hydrochloride, Dosage: 12, 5 Mg/ Ml, Indication:Injectable0268446, Dopamine, Presentation:Injectable Solution0268960, Epinephrine, Dosage: 1Mg/Ml, Use:Injectable Solution0268255, Esketamine, Concentration:50 Mg/Ml, Pharmaceutical Form:Injectable Solution; 2 Ml Ampoule, Scopolamine Butylbromide, Presentation: Associated With Dipyrone Sodium, Dosage: 4Mg + 500Mg/Ml, Indication: Injectable Solution; Ampoule 5 Ml0270621, Dosage:20 Mg/Ml, Indication:Injectable Solution Ampoule 1Ml0267282, Etilephrine Hydrochloride, Composition: 10Mg/Ml, Presentation: